CClinicalTrials.gg
RecruitingNCT07342985LAM-SPUpdated Jan 15, 2026

Impact of Medicalized Residential Care (LAM) on the Development of Care Plans for Vulnerable Patients in Palliative Care

An observational study in Palliative Care, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-15.

Sponsored by University Hospital, Strasbourg, France · Observational

From the registry’s dates

  • Started Oct 2025; still recruiting 11 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the research is to identify the factors influencing the development of care plans for vulnerable patients admitted to medicalized care facilities (LAM) and in palliative care.

02

Conditions studied

  • Palliative Care

Keywords

  • Palliative care
  • Palliative care pathology
03

In context

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult subject residing in one of the two LAM regions of Alsace and suffering from a palliative-care condition (the nature of the condition (or conditions) is not specified)

Inclusion criteria

  • Adult subject (≥18 years old)
  • Subject residing in one of the two LAM regions of Alsace (France) at the time of the study and suffering from a palliative-care condition (the nature of the condition (or conditions) is not specified)

Exclusion criteria

Exclusion Criteria:

- Refusal to participate in the study

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Analysis of Interviewees' Discourse Regarding the Organizational, Human, and Relational Resources Implemented Within the Facilities to Develop a Care Plan

    There is no evaluation in this study: it simply aims to identify the factors influencing the development of care plans for vulnerable patients requiring palliative care and admitted to medical facilities (LAM)

    Time frame: Up to 12 months

07

Study locations

1 of 1 sites recruiting
  • Service d'Accompagnement et de Soins Palliatifs - CHU de Strasbourg - France
    Strasbourg, 67091, France
    • Johanna Laplace, MD · Contact · johanna.laplace@chru-strasbourg.fr · 33 3 88 11 65 80
    • Johanna LAPLACE, MD · Principal investigator
    • Claire SIBILLE, MD · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07342985
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Jan 15, 2026
Start date
Oct 10, 2025
Primary completion
Oct 2026 (estimated)
Completion
Oct 10, 2026 (estimated)
Last update
Jan 15, 2026

Study contacts

Johanna LAPLACE, MD
Contact
johanna.laplace@chru-strasbourg.fr
33 3 88 11 65 80

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion